The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Open accessAbstract
Although CRISPR-Cas9 nucleases are widely used for genome editing, the range of sequences that Cas9 can recognize is constrained by the need for a specific protospacer adjacent motif (PAM). As a result, it can often be difficult to target double-stranded breaks (DSBs) with the precision that is necessary for various genome-editing applications. The ability to engineer Cas9 derivatives with purposefully altered PAM specificities would address this limitation. Here we show that the commonly used Streptococcus pyogenes Cas9 (SpCas9) can be modified to recognize alternative PAM sequences using structural information, bacterial selection-based directed evolution, and combinatorial design. These altered PAM specificity variants enable robust editing of endogenous gene sites in zebrafish and human cells not currently targetable by wild-type SpCas9, and their genome-wide specificities are comparable to wild-type SpCas9 as judged by GUIDE-seq analysis. In addition, we identify and characterize another SpCas9 variant that exhibits improved specificity in human cells, possessing better discrimination against off-target sites with non-canonical NAG and NGA PAMs and/or mismatched spacers. We also find that two smaller-size Cas9 orthologues, Streptococcus thermophilus Cas9 (St1Cas9) and Staphylococcus aureus Cas9 (SaCas9), function efficiently in the bacterial selection systems and in human cells, suggesting that our engineering strategies could be extended to Cas9s from other species. Our findings provide broadly useful SpCas9 variants and, more importantly, establish the feasibility of engineering a wide range of Cas9s with altered and improved PAM specificities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Precision editing of alleles in a human cell has drastically improved the understanding of genotypic and phenotypic effects in gene therapy due to the lower off-target rates [119,120,121].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides, there are other variants that could identify different PAM sequences, such as VQR, VRER, VRQR, and QQR1, allowing gene editing on a wider range of genetic loci.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The basic bacterial selection scheme performed was adapted from a previously described positive selection system for identifying Cas9 mutants in E. coli31.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“To be applicable to a wider range of genomic sites, some non-NGG PAM Cas9 were generated.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“This could result in the development of wider-ranged VQR, EQR, and VRER SpCas9 variants, enabling the targeting of NGAN, NGNG, and NGCG PAMs, respectively (Kleinstiver et al., 2015; Hirano et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Kleinstiver et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“These modifications have led to the creation of SpCas9 variants such as VQR, EQR, and VRER, which can recognize broader PAM sequences like NGAN, NGNG, and NGCG, respectively (Kleinstiver et al., 2015; Hirano et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Kleinstiver et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 genomic localization is delimited by the protospacer adjacent motif (PAM), which is NGG for SpCas9 while evolved variants of SpCas9 tolerate a broader range of PAM sequences17–21.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [18]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This screen identified four key beneficial point mutations in SpCas9, giving rise to evoCas9, a variant that exhibits fidelity exceeding SpCas9-HF1 and eSpCas9 (Kleinstiver et al., 2015; Casini et al., 2018).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Kleinstiver et al., 2015
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“SaKKHcas9 is an evolved variant of SaCas9 and recognizes the more relaxed NNNRRT PAM18.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Self-citationCRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,001
CRISPR-based genome editing technology and its applications in oil crops
He, J., Zhang, K., Tang, M., Zhou, W., Chen, L., Chen, Z., & Li, M. (2021) · Oil Crop Science · doi:10.1016/j.ocsci.2021.07.002 · Cited by 24
Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing
Liu, X., Xiong, W., Qi, Q., Zhang, Y., Ji, H., Cui, S., An, J., Sun, X., Yin, H., Tian, T., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac255 · Cited by 25
CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha
Sugano, S. S., & Nishihama, R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8657-6_7 · Cited by 24
CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment
Kaushik, I., Ramachandran, S., & Srivastava, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.018 · Cited by 25
Collias, D., Leenay, R. T., Slotkowski, R., Zuo, Z., Collins, S. P., McGirr, B. A., Liu, J., & Beisel, C. L. (2020) · Science Advances · doi:10.1126/sciadv.abb4054 · Cited by 24
CRISPR Technology for Genome Activation and Repression in Mammalian CellsPreprint
Du, D., & Qi, L. S. (2016) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot090175 · Cited by 24
Musolino, P. L., Rosser, S. J., Brittan, M., Newby, D. E., Berry, C., Riley, P. R., Giacca, M., Hajjar, R. J., & Baker, A. H. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf109 · Cited by 23
Research progress of base editing and prime editing tools based on the CRISPR/Cas system
Gao, H., Gao, S., Kan, G., Valentovich, L. N., & An, Y. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102771 · Cited by 26
Cas9 Variants Expand the Target Repertoire in Caenorhabditis elegans
Bell, R. T., Fu, B. X. H., & Fire, A. Z. (2015) · Genetics · doi:10.1534/genetics.115.185041 · Cited by 23
Future of human mitochondrial DNA editing technologies
Verechshagina, N. A., Nikitchina, N., Yamada, Y., Harashima, Н., Tanaka, M., Orishchenko, К. E., & Mazunin, I. (2018) · Mitochondrial DNA Part A · doi:10.1080/24701394.2018.1472773 · Cited by 23
Therapeutic application of the CRISPR system: current issues and new prospects
Lee, M., & Kim, S. (2019) · Human Genetics · doi:10.1007/s00439-019-02028-2 · Cited by 23
Modification of Cas9, gRNA and PAM: Key to further regulate genome editing and its applications
Gupta, R. K., Gupta, D., Kazi, T. A., Dey, D., Singh, R., Swarnakar, S., Ravichandiran, V., Roy, S., & Ghosh, D. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.001 · Cited by 23
Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG
Yu, S.-Y., Birkenshaw, A., Thomson, T., Carlaw, T., Zhang, L., & Ross, C. J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0109 · Cited by 23
Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition
Kang, M., Zuo, Z., Yin, Z., & Gu, J. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01562 · Cited by 23
Capturing nucleic acid variants with precision using CRISPR diagnostics
Kumar, M., Maiti, S., & Chakraborty, D. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114712 · Cited by 25
CRISPR/Cas-Based Techniques for Live-Cell Imaging and Bioanalysis
Huang, S., Dai, R., Zhang, Z., Zhang, H., Zhang, M., Li, Z., Zhao, K., Xiong, W., Cheng, S., Wang, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713447 · Cited by 25
Self-citationCoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing
Pedrazzoli, E., Demozzi, M., Visentin, E., Ciciani, M., Bonuzzi, I., Pezzè, L., Lucchetta, L., Maule, G., Amistadi, S., Esposito, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47800-9 · Cited by 26
Cheng, J., Roden, C., Pan, W. Q., Zhu, S., Eastman, A. E., Pan, X., Jiang, T., Kluger, Y., Weissman, S. M., Guo, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms11178 · Cited by 23
Genome engineering tools for building cellular models of disease
Lin, J. J., & Musunuru, K. (2016) · FEBS Journal · doi:10.1111/febs.13763 · Cited by 23
Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
Feng, Y., Chen, C., Han, Y., Chen, Z., Lu, X., Liang, F., Li, S., Qin, W., & Lin, S. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.031914 · Cited by 23
CRISPR Editing Technology in Biological and Biomedical Investigation
White, M. K., Kaminski, R., Young, W., Roehm, P. C., & Khalili, K. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26099 · Cited by 25
SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power
Zhang, D., & Zhang, B. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.05.001 · Cited by 23
Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes
Huang, B., Johansen, K. H., & Schwartzberg, P. L. (2018) · Current Protocols in Immunology · doi:10.1002/cpim.62 · Cited by 24
Joberty, G., Fälth-Savitski, M., Paulmann, M., Böesche, M., Doce, C., Cheng, A. T., Drewes, G., & Grandi, P. (2020) · The CRISPR Journal · doi:10.1089/crispr.2019.0064 · Cited by 25
Prediction of sgRNA Off-Target Activity in CRISPR/Cas9 Gene Editing Using Graph Convolution Network
Vinodkumar, P. K., Ozcinar, C., & Anbarjafari, G. (2021) · Entropy · doi:10.3390/e23050608 · Cited by 22
Points of View on the Tools for Genome/Gene Editing
Chuang, C.-K., & Lin, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189872 · Cited by 26
Zhou, W., Yang, J., Zhang, Y., Hu, X., & Wang, W. (2022) · MedComm · doi:10.1002/mco2.155 · Cited by 23
CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies
Chey, Y. C. J., Arudkumar, J., Aartsma-Rus, A. M., Adikusuma, F., & Thomas, P. Q. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1580 · Cited by 24
Genetically engineered zebrafish as models of skeletal development and regeneration
Henke, K., Farmer, D. T., Niu, X., Kraus, J. M., Galloway, J. L., & Youngstrom, D. W. (2022) · Bone · doi:10.1016/j.bone.2022.116611 · Cited by 22
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
Li, Y.-R., Lyu, Z., Tian, Y., Fang, Y., Zhu, Y., Chen, Y., & Yang, L. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100733 · Cited by 23
Phage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM
Qi, T., Wang, Y., Yang, Y., Gao, S., Liu, J., Huang, Q., Tian, Y., Tang, J., Zheng, W., & Wang, Y. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01481-5 · Cited by 23
Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing
Vlashi, R., Zhang, X., Li, H., & Chen, G. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09860-y · Cited by 24
Deshpande, K. S., Vyas, A. K., Balakrishnan, A., & Vyas, D. (2015) · American Journal of Robotic Surgery · doi:10.1166/ajrs.2015.1023 · Cited by 22
Targeted candidate gene screens using CRISPR/Cas9 technology
Shah, A. N., Moens, C. B., & Miller, A. C. (2016) · Methods in cell biology · doi:10.1016/bs.mcb.2016.01.008 · Cited by 22
Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease
Lau, C., & Suh, Y. (2016) · Gerontology · doi:10.1159/000452972 · Cited by 22
CRISPR Knockouts in Ciona Embryos
Gandhi, S., Razy‐Krajka, F., Christiaen, L., & Stolfi, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-7545-2_13 · Cited by 23
CRISPR‐Cas9: A cornerstone for the evolution of precision medicine
Razzouk, S. (2018) · Annals of Human Genetics · doi:10.1111/ahg.12271 · Cited by 22
Improved CRISPR‐Cas12a‐assisted one‐pot DNA editing method enables seamless DNA editing
Wang, L., Wang, H., Liu, H., Zhao, Q., Liu, B., Wang, L., Zhang, J., Zhu, J., Bao, R., & Luo, Y. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26938 · Cited by 23
CRISPR-Cas “Non-Target” Sites Inhibit On-Target Cutting Rates
Moreb, E. A., Hutmacher, M., & Lynch, M. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0065 · Cited by 23
CRISPR/CAS9, the king of genome editing tools
Банников, А. В., & Лавров, А. В. (2017) · Molecular Biology · doi:10.1134/s0026893317040033 · Cited by 22
Cell-free systems: A synthetic biology tool for rapid prototyping in metabolic engineering
Jeung, K., Kim, M., Jang, E., Shon, Y. J., & Jung, G. Y. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108522 · Cited by 21
Menon, A. V., Song, B., Chao, L., Sriram, D., Chansky, P. A., Bakshi, I., Ulianova, J., & Li, W. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1565387 · Cited by 21
Zheng, X., Qi, C., Yang, L., Quan, Q., Liu, B., Zhong, Z., Tang, X. D., Fan, T., Zhou, J., & Zhang, Y. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00621 · Cited by 22
Asano, Y., Yamashita, K., Hasegawa, A., Ogasawara, T., Iriki, H., & Muramoto, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-89546-0 · Cited by 24
Takasugi, P., Wang, S., Truong, K. T., Drage, E. P., Kanishka, S. N., Higbee, M. A., Bamidele, N., Ojelabi, O., Sontheimer, E. J., & Gagnon, J. A. (2021) · Genetics · doi:10.1093/genetics/iyab196 · Cited by 23
Lu, Y., Mbakam, C. H., Song, B., Bendavid, E., & Tremblay, J. P. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.892769 · Cited by 22
Wang, T., Wang, Y., Chen, P., Yin, B., & Ye, B. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02617 · Cited by 21
Nanomedicine for Treating Muscle Dystrophies: Opportunities, Challenges, and Future Perspectives
Ahmed, Z., & Qaisar, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231912039 · Cited by 21
Expanding the Scope of Bacterial CRISPR Activation with PAM-Flexible dCas9 Variants
Kiattisewee, C., Karanjia, A. V., Legut, M., Daniloski, Z., Koplik, S. E., Nelson, J., Kleinstiver, B. P., Sanjana, N. E., Carothers, J. M., & Zalatan, J. G. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00405 · Cited by 21
Self-citationSeo, S.-Y., Min, S., Lee, S., Seo, J. H., Park, J., Kim, H. K., Song, M., Baek, D., Cho, S., & Kim, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01875-2 · Cited by 21
Kalamakis, G., & Platt, R. J. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.021 · Cited by 20
Plant conservation in the age of genome editing: opportunities and challenges
Yin, K., Chung, M. Y., Lan, B., Du, F., & Chung, M. G. (2024) · Genome biology · doi:10.1186/s13059-024-03399-0 · Cited by 24
Engineering nucleic acid chemistry for precise and controllable CRISPR/Cas9 genome editing
Cai, W., & Wang, M. (2019) · 中国科学通报：英文版 · doi:10.1016/j.scib.2019.07.035 · Cited by 21
Advances in engineering CRISPR-Cas9 as a molecular Swiss Army knife
Meaker, G. A., Hair, E. J., & Gorochowski, T. E. (2020) · Synthetic Biology · doi:10.1093/synbio/ysaa021 · Cited by 22
Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s
Hou, S., Lee, J. M., Myint, W., Matsuo, H., Yılmaz, N. K., & Schiffer, C. A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100909 · Cited by 22
Villiger, L., Schmidheini, L., Mathis, N., Rothgangl, T., Marquart, K. F., & Schwank, G. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.025 · Cited by 21
CRISPR-Cas technology for rapid detection of pathogens
Daneshgar, H., Safarkhani, M., Sojdeh, S., Bagherzadeh, M., & Rabiee, N. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118174 · Cited by 22
Lokya, V., Singh, S., Chaudhary, R., Jangra, A., & Tiwari, S. (2025) · Plant Molecular Biology · doi:10.1007/s11103-025-01600-x · Cited by 21
Targeted genome engineering in Caenorhabditis elegans
Chen, X., Feng, X., & Guang, S. (2016) · Cell & Bioscience · doi:10.1186/s13578-016-0125-3 · Cited by 20
CRISPR screening strategies for microRNA target identification
Yang, B., & McJunkin, K. (2020) · FEBS Journal · doi:10.1111/febs.15218 · Cited by 20
Sophisticated CRISPR/Cas tools for fine-tuning plant performance
Capdeville, N., Merker, L., Schindele, P., & Puchta, H. (2020) · Journal of Plant Physiology · doi:10.1016/j.jplph.2020.153332 · Cited by 21
Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
Tao, Y., Duan, Y., Tsang, H. W. S., Xu, H. J., Chen, Y., Cao, H., Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2021) · Communications Biology · doi:10.1038/s42003-021-01722-0 · Cited by 21
Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application
Sun, B., Chen, H., & Gao, X. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.007 · Cited by 20
Siew, W. S., Tang, Y.-Q., Kong, C. K., Goh, B. H., Zacchigna, S., Dua, K., Chellappan, D. K., Duangjai, A., Saokaew, S., Phisalprapa, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168422 · Cited by 21
Tissue Specific DNA Repair Outcomes Shape the Landscape of Genome Editing
Meyenberg, M., da Silva, J. F., & Loizou, J. I. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.728520 · Cited by 21
Chen, Y., Luo, X. L., Kang, R., Cui, K., Ou, J., Zhang, X., & Liang, P. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.07.007 · Cited by 23
Yang, Y., Li, J., Zou, Q., Ruan, Y., & Feng, H. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.018 · Cited by 21
Genetic Databases and Gene Editing Tools for Enhancing Crop Resistance against Abiotic Stress
Joshi, A. B., Yang, S.-Y., Song, H.-G., Min, J., & Lee, J.-H. (2023) · Biology · doi:10.3390/biology12111400 · Cited by 21
Fujii, W., Kakuta, S., Yoshioka, S., Kyuwa, S., Sugiura, K., & Naito, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.070 · Cited by 20
CORALINA: a universal method for the generation of gRNA libraries for CRISPR-based screening
Köferle, A., Worf, K., Breunig, C., Baumann, V., Herrero, J., Wiesbeck, M. F., Hutter, L. H., Götz, M., Fuchs, C., Beck, S., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3268-z · Cited by 20
Applications of CRISPR genome editing technology in drug target identification and validation
Lu, Q., Livi, G. P., Modha, S. S., Yusa, K., Macarrón, R., & Dow, D. J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1317244 · Cited by 21
Targeted genome editing in Caenorhabditis elegans using CRISPR /Cas9
Farboud, B. (2017) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.287 · Cited by 20
Genetic improvement of horticultural crops mediated by CRISPR/Cas: a new horizon of possibilities
Koltun, A., Corte, L. E.-D., Mertz-Henning, L. M., & Gonçalves, L. S. (2018) · Horticultura Brasileira · doi:10.1590/s0102-053620180302 · Cited by 20
Gene delivery methods and genome editing of human pluripotent stem cells
Czerwińska, P., Mazurek, S., Kołodziejczak, I., & Wiznerowicz, M. (2019) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2019.01.007 · Cited by 20
Schultzhaus, Z. S., Wang, Z., & Stenger, D. A. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115275 · Cited by 20
A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins
Gama-Brambila, R. A., Chen, J., Dabiri, Y., Tascher, G., Němec, V., Münch, C., Song, G., Knapp, S., & Cheng, X. (2021) · JACS Au · doi:10.1021/jacsau.1c00007 · Cited by 21
Gong, G., Zhang, Y., Wang, Z., Liu, L., Shi, S., Siewers, V., Yuan, Q., Nielsen, J., Zhang, X., & Liu, Z. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00560 · Cited by 22
Kumar, U., Dwivedi, D., & Das, U. (2025) · Biotechnology Journal · doi:10.1002/biot.70148 · Cited by 21
Synthetic Biology of Plants and Microbes for Agriculture, Environment, and Future Applications
Clauer, P. R., Nou, A., Toth, T., Yu, Q., Chemla, Y., Boo, A., Yoon, K. S., & Voigt, C. A. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00687 · Cited by 21
Customizing CRISPR–Cas PAM specificity with protein language models
Nayfach, S., Bhatnagar, A., Novichkov, A., Kim, N., Hoffnagle, A. M., Hussain, R., Estevam, G. O., Hill, E., Ruffolo, J. A., Silverstein, R. A., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-025-02995-0 · Cited by 19
Self-citationSingle‐nucleotide editing: From principle, optimization to application
Tang, J., Lee, T., & Sun, T. (2019) · Human Mutation · doi:10.1002/humu.23819 · Cited by 18
Recent advances in developing and applying biosensors for synthetic biology
Jones, K. A., Zinkus-Boltz, J., & Dickinson, B. C. (2019) · Nano Futures · doi:10.1088/2399-1984/ab4b78 · Cited by 20
Optogenetics and CRISPR: A New Relationship Built to Last
Mathony, J., Hoffmann, M. D., & Niopek, D. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0755-8_18 · Cited by 20
Versatile CRISPR/Cas9 Systems for Genome Editing in Ustilago maydis
Wege, S.-M., Gejer, K., Becker, F., Bölker, M., Freitag, J., & Sandrock, B. (2021) · Journal of Fungi · doi:10.3390/jof7020149 · Cited by 19
Mechanistic insights into the versatile class II CRISPR toolbox
Zhang, F., & Huang, Z. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.11.007 · Cited by 20
Huang, C., Li, Q., & Li, J. (2022) · Medical Review · doi:10.1515/mr-2022-0029 · Cited by 20
Conformational dynamics of CasX (Cas12e) in mediating DNA cleavage revealed by single-molecule FRET
Xing, W., Li, D., Wang, W., Liu, J., & Chen, C. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae604 · Cited by 19
Application of CRISPR-mediated genome engineering in cancer research
Sayin, V. I., & Papagiannakopoulos, T. Y. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.029 · Cited by 20
Raper, A. T., Stephenson, A. A., & Suo, Z. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05469 · Cited by 19
Double Selection Enhances the Efficiency of Target-AID and Cas9-Based Genome Editing in Yeast
Després, P. C., Dubé, A. K., Nielly‐Thibault, L., Yachie, N., & Landry, C. R. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200461 · Cited by 19
Blossom of CRISPR technologies and applications in disease treatment
Liu, H., Wang, L., & Luo, Y. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.10.003 · Cited by 19
CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene
Yrigollen, C. M., & Davidson, B. L. (2019) · Brain Sciences · doi:10.3390/brainsci9010017 · Cited by 19
Endogenous CRISPR/Cas9 arrays for scalable whole-organism lineage tracing
Cotterell, J., Vila-Cejudo, M., Batlle‐Morera, L., & Sharpe, J. A. (2020) · Development · doi:10.1242/dev.184481 · Cited by 20
CRISPR Systems Suitable for Single AAV Vector Delivery
Stevanovic, M., Piotter, E., McClements, M. E., & MacLaren, R. E. (2021) · Current Gene Therapy · doi:10.2174/1566523221666211006120355 · Cited by 19
Vanoli, F., & Jasin, M. (2017) · Methods · doi:10.1016/j.ymeth.2017.05.006 · Cited by 19
Next-generation mammalian genetics toward organism-level systems biology
Susaki, E. A., Ukai, H., & Ueda, H. R. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0015-2 · Cited by 21
Tian, K. V., Guo, Y., Zou, B., Wang, L., Zhang, Y., Qi, Z., Zhou, J., Wang, X., Zhou, G., Wei, L., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa843 · Cited by 18
Li, F., Mas, A., Dürr, A., Keiser, M. S., Cheng, C., Harapanahalli, A., Gonzalez‐Alegre, P., Davidson, B. L., & Wang, K. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100146 · Cited by 18
In vivo base editing rescues primary hyperoxaluria type 1 in rats
Chen, Z., Zhang, D., Zheng, R., Yang, L., Huo, Y., Zhang, D., Fang, X., Li, Y., Xu, G., Li, D., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.11.029 · Cited by 19
Discovery and structural mechanism of DNA endonucleases guided by RAGATH-18-derived RNAs
Ren, K., Zhou, F., Zhang, F., Yin, M., Zhu, Y., Wang, S., Chen, Y., Huang, T., Wu, Z., He, J., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00952-1 · Cited by 18
Metadata
- Authors
- Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P. W., Li, Z., Peterson, R. T., Yeh, J.-R. J., Aryee, M. J., & Joung, J. K.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Corresponding author
- Joung, J. Keith
- ORCID
- Venue
- Nature
- Published
- 2015-06-22
- Volume
- 523
- Issue
- 7561
- Pages
- 481-485
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4540238
- OpenAlex
- W4245053291
- Semantic Scholar
- afe29e1767b5d0f3563ee9f2c1a586a9d5e8cb9b
- Cited by
- 1,624
- References
- 36
- Citations by year
- 2026: 58 · 2025: 105 · 2024: 117 · 2023: 134 · 2022: 166 · 2021: 165 · 2020: 164 · 2019: 154 · 2018: 147 · 2017: 186 · 2016: 167 · 2015: 58
- FWCI
- 80.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of General Medical Sciences (DP1GM105378, R01GM107427, R01GM088040)
- National Center for Chronic Disease Prevention and Health Promotion (DP1 GM105378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, SpCas9, protospacer adjacent motif, genome editing, off-target effects, SaCas9, Cas9 nickase, zebrafish
- MeSH terms
- Animals, Cell Line, Humans, Mutation, Staphylococcus aureus, Streptococcus pyogenes, Substrate Specificity, Zebrafish, Protein Engineering, Genome, Directed Molecular Evolution, Amino Acid Substitution, Streptococcus thermophilus, Nucleotide Motifs, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
